# Dexmedetomidine Infusion and Postoperative Lung Aeration After Thoracic Surgery

> **NCT06502002** · NA · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 100 (actual)

## Conditions studied

- Surgery-Complications
- Respiratory Complication
- Lung Injury, Acute

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06502002
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-01
- **Primary completion:** 2025-11-13
- **Final completion:** 2025-11-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06502002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06502002, "Dexmedetomidine Infusion and Postoperative Lung Aeration After Thoracic Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06502002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
